top of page

The GLP-1 Revolution: More Than Just a Weight Loss Trend


By Mohsen Halaby, MD

Board-Certified Internal Medicine

Carebridge Medical | Serving Ohio


Glucagon-like peptide-1 (GLP-1) medications have rapidly transformed the way we treat obesity and type 2 diabetes. What started as a diabetes therapy has evolved into one of the most significant breakthroughs in metabolic medicine in decades.

But what exactly is GLP-1? And why is it such a big deal?

What Is GLP-1?

GLP-1 is a naturally occurring gut hormone released after eating. It plays a powerful role in metabolic regulation by:

  • Stimulating insulin secretion

  • Suppressing glucagon

  • Slowing gastric emptying

  • Reducing appetite via brain signaling

GLP-1 receptor agonists are medications designed to mimic and amplify these natural effects.

FDA-Approved GLP-1 Medications

Some of the most well-known GLP-1–based therapies include:

  • Semaglutide (brand names include Ozempic® and Wegovy®)

  • Tirzepatide (brand names include Mounjaro® and Zepbound®)

  • Liraglutide (brand names include Victoza® and Saxenda®)

Tirzepatide is technically a dual GIP/GLP-1 receptor agonist, which may explain its even greater weight loss effect in clinical trials.

How Effective Are They?

Clinical trials show:

  • 10–15% average body weight loss with semaglutide

  • 15–22% average weight loss with tirzepatide

  • Significant improvement in A1c for patients with type 2 diabetes

  • Reduction in cardiovascular risk in high-risk patients

These results approach outcomes previously seen only with bariatric surgery.

Beyond Weight Loss

GLP-1 medications are now being studied for:

  • Cardiovascular protection

  • Fatty liver disease (MASLD)

  • Sleep apnea

  • Kidney protection

  • Possibly neuroprotective effects

This suggests GLP-1 therapy may be part of a broader metabolic disease strategy — not just a cosmetic weight solution.

Common Side Effects

Most side effects are gastrointestinal and dose-dependent:

  • Nausea

  • Vomiting

  • Constipation

  • Bloating

These are usually temporary and can be minimized with slow dose titration.

Rare but important considerations include:

  • History of medullary thyroid carcinoma

  • History of pancreatitis

A thorough medical evaluation is essential before starting therapy.

Who Is a Good Candidate?

GLP-1 therapy may be appropriate for:

  • BMI ≥30

  • BMI ≥27 with obesity-related conditions (hypertension, diabetes, sleep apnea)

  • Patients with type 2 diabetes needing better glycemic control

  • Individuals who have struggled with traditional lifestyle-based weight loss

GLP-1 medications work best when combined with nutrition guidance, strength training, sleep optimization, and long-term medical follow-up.

The Future of Metabolic Medicine

We are entering an era where obesity is increasingly treated as a chronic metabolic disease rather than a failure of willpower. GLP-1 therapies represent a shift toward biologically targeted, evidence-based treatment.

When prescribed responsibly and monitored appropriately, these medications can be transformative.

How We Approach GLP-1 Therapy

At Carebridge, we evaluate each patient individually before initiating medical weight management. Our approach includes:

  • Comprehensive metabolic review

  • Risk stratification

  • Ongoing monitoring

  • Personalized lifestyle guidance

GLP-1 therapy is not a shortcut — it’s a tool. The goal is sustainable metabolic health, not temporary weight loss.


GLP-1 Therapy at Carebridge

At Carebridge, medical weight management is physician-led and evidence-based. We do not treat weight loss as a cosmetic service — we treat metabolic disease.

Our GLP-1 program includes:

  • Comprehensive medical evaluation

  • Review of labs and metabolic risk factors

  • Medications selection based on clinical profile

  • Structured dose titration and side-effect monitoring

  • Ongoing virtual follow-up

  • Nutrition and lifestyle guidance

Carebridge provides virtual care to adult patients in Ohio offering convenient access to board-certified internal medicine oversight without the delays of traditional clinics.

Our goal is long-term metabolic health — not rapid, unsupervised weight loss.

Want to Learn More?

If you’re interested in physician-supervised medical weight management, including GLP-1 therapy, schedule a consultation with Carebridge today.

Disclaimer

This article is for educational purposes only and does not constitute medical advice. GLP-1 medications require medical evaluation and prescription. Individual results vary. Consult a qualified healthcare professional before starting any treatment.

Comments


© 2026 CareBridge Medical

Carebridge Medical is an independent, physician-led telemedicine practice serving Ohio and California. We are not affiliated with any other companies using the name “Carebridge.”

Not insurance. Not for emergencies.

Terms of use

Privacy policy

HIPAA

bottom of page